Skip to content

AARD AARD Market capitalization

Market capitalization at other companies

AbbVie logo
AbbVieABBV
$384.69B+3.8%
Relmada Therapeutics, Inc. logo
Relmada Therapeutics, Inc.RLMD
$730.04M+8,046%
Rhythm Pharmaceuticals, Inc. logo
Rhythm Pharmaceuticals, Inc.RYTM
$5.94B+77.3%
Aquestive Therapeutics, Inc. logo
Aquestive Therapeutics, Inc.AQST
$506.49M+76.6%
Viking Therapeutics logo
Viking TherapeuticsVKTX
$3.76B+38.7%
Arvinas logo
ArvinasARVN
$677.99M+40.4%

Other financials

Income statement

See full
Revenue-
Operating income-$22.5M-115%
Net income-$21.6M-132%
EPS (diluted)-$0.99-39.4%

Balance sheet

See full
Cash & equivalents$62.4M+136%
Total debt$336.0K-53.7%
Total equity$87.0M-42.3%
Total assets$98.6M-37.2%

Cash flow

See full
Operating cash flow-$18.9M-65.7%
CapEx--100%
Free cash flow-$16.8M-117%

Valuation

See full
Enterprise value$62.25M-77.4%

Returns & leverage

See full
Return on equity-58.8%
Debt / equity0.0×
Current ratio8.1×-17.8×

Where this comes from

Computed from the period-end share price: $82.25M.

The official record: AARD’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about AARD's market capitalization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AARD's market capitalization?
AARD (AARD) reported market capitalization of $82.25M in Q1 2026.
What does market capitalization mean?
The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.